MDGL logo

Madrigal Pharmaceuticals, Inc. (MDGL) Cash From Operations

Annual CFO:

-$455.57M-$131.34M(-40.51%)
December 31, 2024

Summary

  • As of today, MDGL annual cash from operations is -$455.57 million, with the most recent change of -$131.34 million (-40.51%) on December 31, 2024.
  • During the last 3 years, MDGL annual cash from operations has fallen by -$271.65 million (-147.71%).
  • MDGL annual cash from operations is now -1773.54% below its all-time high of $27.22 million, reached on December 31, 2007.

Performance

MDGL Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

Quarterly CFO:

-$47.05M+$41.84M(+47.07%)
June 30, 2025

Summary

  • As of today, MDGL quarterly cash from operations is -$47.05 million, with the most recent change of +$41.84 million (+47.07%) on June 30, 2025.
  • Over the past year, MDGL quarterly cash from operations has increased by +$87.89 million (+65.13%).
  • MDGL quarterly cash from operations is now -168.82% below its all-time high of $68.37 million, reached on December 31, 2007.

Performance

MDGL Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

TTM CFO:

-$307.41M+$87.89M(+22.23%)
June 30, 2025

Summary

  • As of today, MDGL TTM cash from operations is -$307.41 million, with the most recent change of +$87.89 million (+22.23%) on June 30, 2025.
  • Over the past year, MDGL TTM cash from operations has increased by +$141.54 million (+31.53%).
  • MDGL TTM cash from operations is now -1115.29% below its all-time high of $30.28 million, reached on June 30, 2016.

Performance

MDGL TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MDGL Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-40.5%+65.1%+31.5%
3Y3 Years-147.7%+18.0%-53.0%
5Y5 Years-994.5%-94.0%-167.6%

MDGL Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-147.7%at lowat high+68.5%-43.4%+32.5%
5Y5-Year-994.5%at low-8.3%+68.5%-167.6%+32.5%
All-TimeAll-Time-1773.5%at low-168.8%+68.5%-1115.3%+32.5%

MDGL Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$47.05M(+47.1%)
-$307.41M(+22.2%)
Mar 2025
-
-$88.89M(+14.9%)
-$395.31M(+13.2%)
Dec 2024
-$455.57M(-40.5%)
-$104.49M(-56.0%)
-$455.57M(-5.7%)
Sep 2024
-
-$66.98M(+50.4%)
-$431.02M(+4.0%)
Jun 2024
-
-$134.94M(+9.5%)
-$448.95M(-15.3%)
Mar 2024
-
-$149.16M(-86.6%)
-$389.32M(-20.1%)
Dec 2023
-$324.23M(-44.2%)
-$79.93M(+5.9%)
-$324.23M(-7.1%)
Sep 2023
-
-$84.92M(-12.8%)
-$302.81M(-9.3%)
Jun 2023
-
-$75.31M(+10.4%)
-$276.96M(-6.9%)
Mar 2023
-
-$84.07M(-43.7%)
-$259.01M(-15.2%)
Dec 2022
-$224.86M(-22.3%)
-$58.52M(+0.9%)
-$224.86M(-4.9%)
Sep 2022
-
-$59.07M(-3.0%)
-$214.39M(-6.7%)
Jun 2022
-
-$57.36M(-14.9%)
-$200.88M(-5.5%)
Mar 2022
-
-$49.91M(-3.9%)
-$190.40M(-3.5%)
Dec 2021
-$183.92M(-16.7%)
-$48.05M(-5.5%)
-$183.92M(+3.6%)
Sep 2021
-
-$45.56M(+2.8%)
-$190.81M(+1.2%)
Jun 2021
-
-$46.88M(-7.9%)
-$193.11M(-13.3%)
Mar 2021
-
-$43.43M(+21.0%)
-$170.48M(-8.2%)
Dec 2020
-$157.56M(-278.5%)
-$54.95M(-14.8%)
-$157.56M(-37.1%)
Sep 2020
-
-$47.85M(-97.3%)
-$114.90M(-46.6%)
Jun 2020
-
-$24.26M(+20.5%)
-$78.37M(-19.4%)
Mar 2020
-
-$30.51M(-148.4%)
-$65.65M(-57.7%)
Dec 2019
-$41.62M(-63.2%)
-$12.28M(-8.5%)
-$41.62M(-16.9%)
Sep 2019
-
-$11.32M(+1.9%)
-$35.61M(-20.6%)
Jun 2019
-
-$11.54M(-78.1%)
-$29.52M(-26.5%)
Mar 2019
-
-$6.48M(-3.4%)
-$23.34M(+8.5%)
Dec 2018
-$25.51M(-14.3%)
-$6.26M(-19.6%)
-$25.51M(-1.3%)
Sep 2018
-
-$5.24M(+2.3%)
-$25.19M(-1.2%)
Jun 2018
-
-$5.36M(+38.0%)
-$24.90M(+8.4%)
Mar 2018
-
-$8.64M(-45.4%)
-$27.19M(-21.8%)
Dec 2017
-$22.32M(-26.7%)
-$5.95M(-20.1%)
-$22.32M(-3.1%)
Sep 2017
-
-$4.95M(+35.3%)
-$21.65M(+16.5%)
Jun 2017
-
-$7.65M(-102.9%)
-$25.94M(-23.9%)
Mar 2017
-
-$3.77M(+28.6%)
-$20.94M(-18.9%)
Dec 2016
-$17.61M(-460.4%)
-$5.28M(+42.9%)
-$17.61M(-31.2%)
Sep 2016
-
-$9.24M(-249.2%)
-$13.42M(-144.3%)
Jun 2016
-
-$2.65M(-504.3%)
$30.28M(+99.3%)
Mar 2016
-
-$438.00K(+60.0%)
$15.20M(+583.6%)
Dec 2015
-$3.14M
-$1.10M(-103.2%)
-$3.14M(+85.2%)
DateAnnualQuarterlyTTM
Sep 2015
-
$34.46M(+294.4%)
-$21.26M(+71.4%)
Jun 2015
-
-$17.73M(+5.6%)
-$74.29M(+4.1%)
Mar 2015
-
-$18.77M(+2.3%)
-$77.43M(+1.9%)
Dec 2014
-$78.92M(-2.0%)
-$19.21M(-3.5%)
-$78.92M(-32.2%)
Sep 2014
-
-$18.57M(+11.1%)
-$59.71M(-45.1%)
Jun 2014
-
-$20.87M(-3.0%)
-$41.14M(-2.4%)
Mar 2014
-
-$20.27M(-1.8%)
-$40.19M(+40.8%)
Dec 2013
-$77.41M(-43.0%)
-
-
Jun 2013
-
-$19.92M(+10.3%)
-$67.92M(-11.2%)
Mar 2013
-
-$22.21M(-77.4%)
-$61.09M(-12.9%)
Dec 2012
-$54.13M(-14.5%)
-$12.52M(+5.6%)
-$54.13M(-3.9%)
Sep 2012
-
-$13.26M(-1.3%)
-$52.10M(-2.8%)
Jun 2012
-
-$13.10M(+14.2%)
-$50.66M(-1.9%)
Mar 2012
-
-$15.25M(-45.5%)
-$49.72M(-5.1%)
Dec 2011
-$47.30M(-23.8%)
-$10.49M(+11.3%)
-$47.30M(-5.1%)
Sep 2011
-
-$11.82M(+2.7%)
-$45.03M(-8.2%)
Jun 2011
-
-$12.15M(+5.3%)
-$41.63M(-8.3%)
Mar 2011
-
-$12.84M(-56.3%)
-$38.45M(-0.7%)
Dec 2010
-$38.20M(-42.5%)
-$8.21M(+2.5%)
-$38.20M(-2.5%)
Sep 2010
-
-$8.43M(+6.1%)
-$37.25M(-0.5%)
Jun 2010
-
-$8.97M(+28.7%)
-$37.08M(+28.2%)
Mar 2010
-
-$12.59M(-73.3%)
-$51.63M(-92.6%)
Dec 2009
-$26.81M(+29.3%)
-$7.26M(+11.9%)
-$26.81M(-795.8%)
Sep 2009
-
-$8.25M(+64.9%)
-$2.99M(+79.5%)
Jun 2009
-
-$23.52M(-292.4%)
-$14.57M(-45.8%)
Mar 2009
-
$12.23M(-26.1%)
-$9.99M(+73.7%)
Dec 2008
-$37.94M(-239.4%)
$16.55M(+183.5%)
-$37.94M(-373.3%)
Sep 2008
-
-$19.83M(-4.7%)
$13.88M(-24.2%)
Jun 2008
-
-$18.94M(-20.5%)
$18.31M(-25.8%)
Mar 2008
-
-$15.72M(-123.0%)
$24.68M(-9.3%)
Dec 2007
$27.22M(+151.4%)
$68.37M(+543.8%)
$27.22M(+152.2%)
Sep 2007
-
-$15.41M(-22.6%)
-$52.17M(-41.9%)
Jun 2007
-
-$12.57M(+4.6%)
-$36.76M(-51.9%)
Mar 2007
-
-$13.18M(-19.6%)
-$24.19M(-119.6%)
Dec 2006
-$52.98M(+14.4%)
-$11.02M(+17.6%)
-$11.02M(+17.6%)
Dec 2005
-$61.88M(-83.1%)
-
-
Mar 2005
-
-$13.37M
-$13.37M
Dec 2004
-$33.80M(-43.1%)
-
-
Dec 2003
-$23.61M
-
-

FAQ

  • What is Madrigal Pharmaceuticals, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. annual cash from operations year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

What is Madrigal Pharmaceuticals, Inc. annual cash from operations?

The current annual cash from operations of MDGL is -$455.57M

What is the all-time high annual cash from operations for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high annual cash from operations is $27.22M

What is Madrigal Pharmaceuticals, Inc. annual cash from operations year-on-year change?

Over the past year, MDGL annual cash from operations has changed by -$131.34M (-40.51%)

What is Madrigal Pharmaceuticals, Inc. quarterly cash from operations?

The current quarterly cash from operations of MDGL is -$47.05M

What is the all-time high quarterly cash from operations for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high quarterly cash from operations is $68.37M

What is Madrigal Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?

Over the past year, MDGL quarterly cash from operations has changed by +$87.89M (+65.13%)

What is Madrigal Pharmaceuticals, Inc. TTM cash from operations?

The current TTM cash from operations of MDGL is -$307.41M

What is the all-time high TTM cash from operations for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high TTM cash from operations is $30.28M

What is Madrigal Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

Over the past year, MDGL TTM cash from operations has changed by +$141.54M (+31.53%)
On this page